Co-transplantation of MSC in the Setting of Allo-HSCT

  • STATUS
    Recruiting
  • End date
    Dec 1, 2025
  • participants needed
    120
  • sponsor
    Fujian Medical University
Updated on 23 January 2021
graft versus host disease
ejection fraction

Summary

Mesenchymal stem cells (MSCs) are known to exhibit immunomodulatory, anti-inflammatory, and pro-angiogenic properties, and therefore have the potential to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) .The study is aimed to identify and evaluate the potential benefits of MSCs infusion during allogeneic HSCT, with regard to the engraftment, graft versus host disease (GVHD), post-transplant relapse and survival.

Details
Condition Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation
Treatment Cotransplant with MSCs
Clinical Study IdentifierNCT04247945
SponsorFujian Medical University
Last Modified on23 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age less than or equal to 65 yrs?
Gender: Male or Female
Do you have Allogeneic Hematopoietic Stem Cell Transplantation?
Do you have any of these conditions: Allogeneic Hematopoietic Stem Cell Transplantation or Allogeneic Hematopoietic Cell Transplantation?
Signed written informed consent
Aged <65 years
Willing to transplant
Cardiac: Left ventricular ejection fraction 50%
Adequate renal and hepatic function
Performance status: Karnofsky 70%

Exclusion Criteria

Pregnant or lactating females
Any co-morbidity precluding the administration of MSCs
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note